e-learning
resources
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
GERMAN: Genotyping and phenotyping of sarcoidosis
J. Muller-Quernheim (Freiburg, Germany)
Source:
ERS Live 2008
Number:
14
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Muller-Quernheim (Freiburg, Germany). GERMAN: Genotyping and phenotyping of sarcoidosis. ERS Live 2008
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Pulmonary sarcoidosis
Definition and history of sarcoidosis
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Phenotyping sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 111s
Year: 2006
Phenotyping of adult patients with bronchiectasis and Yellow-Nail-Syndrome (YNS)- data from the German and the European Bronchiectasis Registries (PROGNOSIS and EMBARC)
Source: International Congress 2019 – Phenotypes and endotypes of bronchiectasis
Year: 2019
COPD SCREENING THROUGH COPD-6 AND PIKO-6 MICROSPIROMETERS: WHAT DEVICE IS BETTER IN REAL LIFE CLINICAL PRACTICE?
Source: International Congress 2019 – Physiologic assessment of airway diseases
Year: 2019
GRANULOMATOUS-LYMPHOCYTIC INTERSTITIAL LUNG DISEASE (GLILD) IN CVID: A CASE-CONTROL SINGLE CENTER RETROSPECTIVE STUDY
Source: International Congress 2019 – Granulomatous disorders: pathogenesis, epidemiology and clinical issues
Year: 2019
DOES THE BENEFIT FROM PULMONARY REHABILITATION DIFFER BETWEEN PHENOTYPES IN COPD?
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020
LATE-BREAKING ABSTRACT: GENE ENVIRONMENT INTERACTION ANALYSIS OF OBESITY AND ASTHMA
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014
LATE-BREAKING ABSTRACT: ASSOCIATION OF SEVERE EXACERBATION WITH FEV1 DECLINE AND LOSS OF AIRWAY REVERSIBILITY IN ASTHMA
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014
The first designed PCR-RFLP technique for butyrophilin-like 2 rs2076530 polymorphism in sarcoidosis
Source: International Congress 2016 – Molecular targets in pulmonary disease
Year: 2016
LOW LUNG FUCTION AT EARLY ADULTHOOD DOESN´T CHANGE DURING FOLLOW-UP. Results from Lung Development Cohort- University of Granada
Source: Virtual Congress 2020 – Risk factors for chronic lung diseases
Year: 2020
Impact of severe exacerbations on lung function in dupilumab-treated patients: LIBERTY ASTHMA QUEST
Source: Virtual Congress 2021 – Pearls in immunology, outcome studies and clinical trials in asthma, alpha-1 antitrypsin deficiency and COPD
Year: 2021
COPD DIAGNOSIS: DIFFERENCES ACCORDING GENDER
Source: Virtual Congress 2021 – Primary care organisation and epidemiology
Year: 2021
Late Breaking Abstract - Sensibility and specificity of the “SLEEP CLINICAL RECORD” Protocol in Brazilian children.
Source: International Congress 2018 – New ideas about respiratory and sleep physiology in children
Year: 2018
LATE-BREAKING ABSTRACT: PRECLINICAL TESTING OF THERAPEUTIC WNT/beta-CATENIN ACTIVATION IN HUMAN 3D LUNG TISSUE CULTURES
Source: International Congress 2014 – Lung cell biology in injury and repair
Year: 2014
THE NEW OPPORTUNITIES OF THE PERSONALISED PULMONARY REHABILITATION PROGRAMS IN MANAGEMENT OF COPD PATIENTS: TARGETS AND GOALS
Source: International Congress 2019 – Pulmonary rehabilitation for obstructive lung diseases
Year: 2019
SURVIVAL OF THE IDIOPATHIC PULMONARY FIBROSIS (IPF) IN SPAIN. NATIONAL SEPAR REGISTRY
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019
EBUS AND ECONOMIC EVALUATION STUDIES: A LITERATURE REVIEW
Source: International Congress 2019 – Interventional pulmonology: diagnostic techniques and obstructive airway disease
Year: 2019
HOW RAPID CAN "RAPID ON-SITE EVALUATION (ROSE)" BE - OUR EXPERIENCE WITH TOLUIDINE BLUE STAINING - CONCORDANCE BETWEEN ROSE AND FINAL CYTOLOGICAL DIAGNOSIS ON EBUS TBNA SAMPLES
Source: Virtual Congress 2020 – Conventional bronchoscopy
Year: 2020
WHAT TOOLS AND RESOURCES DO PULMONARY REHABILITATION TEAMS USE TO DELIVER EDUCATION?
Source: Virtual Congress 2020 – Optimising the benefits of pulmonary rehabilitation
Year: 2020
INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURE (IPAF): Clinical, radiological and morphologic profile in indian patients.
Source: International Congress 2017 – Novel and old entities
Year: 2017
Polymorphism of p21(Waf1/Cip1) and sarcoidosis
Source: Eur Respir J 2006; 28: Suppl. 50, 352s
Year: 2006
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept